Press Releases

SER strengthens their position as a market leader for executive search in the R&D Biotech industry by partnering with Benchling. Benchling, the market leader in Bioinformatic Technologies has retained SER to help scale sales in the US. Based upon explosive triple digit growth and customer demand, Benchling chose SER to help with their expansion initiative. The decision to go with SER was based upon SER’s extensive network in the R&D Biotech industry, as well as their ability to execute.

“R&D Biotechnology Software is the next big wave of disruptive technology. Our partnership with Benchling will truly allow us to change the world one person at a time” says SER’s Founder & CEO Steve Rosenblum.